
Purdue Pharma, the architect of much of the U.S. opioid epidemic through its aggressive promotion of OxyContin, has once again been sentenced to pay fines-this time $225 million to the Department of Justice in a criminal settlement, with broader bankruptcy proceedings involving billions more from the Sackler family and the company itself (totalling around $5.5–7.4 billion in various penalties and settlements)















